CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
Scripps Health |
Dr. Darryl D. D’Lima |
Quest – Discovery Stage Research Projects |
Meniscal Repair and Regeneration |
$1,361,775 |
Stone Research Foundation |
Dr. Kevin Stone |
Quest – Discovery Stage Research Projects |
A Novel Therapy for Articular Cartilage Autologous Cellular Repair by Paste Grafting |
$1,180,309 |
University of California, San Diego |
Dr. Gene Wei-Ming Yeo |
Quest – Discovery Stage Research Projects |
RNA-directed therapy for Huntington’s disease |
$1,253,110 |
University of California, Irvine |
Dr. Mathew Blurton-Jones |
Quest – Discovery Stage Research Projects |
Transplantation of genetically corrected iPSC-microglia for the treatment of Sanfilippo Syndrome (MPSIIIA) |
$1,083,379 |
University of California, San Francisco |
Dr. Julie Deane Saba |
Quest – Discovery Stage Research Projects |
Providing a cure for sphingosine phosphate lyase insufficiency syndrome (SPLIS) through adeno-associated viral mediated SGPL1 gene therapy |
$1,463,400 |
Calibr |
Luke L Lairson |
Quest – Discovery Stage Research Projects |
Improving the efficacy and tolerability of clinically validated remyelination-inducing molecules using developable combinations of approved drugs |
$1,554,126 |
University of California, San Francisco |
Dr Julia Carnevale |
Quest – Discovery Stage Research Projects |
Generating deeper and more durable BCMA CAR T cell responses in Multiple Myeloma through non-viral knockin/knockout multiplexed genome engineering |
$1,463,368 |
Stanford University |
Sarah Heilshorn |
Quest – Discovery Stage Research Projects |
Injectable, autologous iPSC-based therapy for spinal cord injury |
$789,000 |
Navega Therapeutics |
Ana Maria Moreno |
Quest – Discovery Stage Research Projects |
Optimization of a gene therapy for inherited erythromelalgia in iPSC-derived neurons |
$1,157,313 |
Cedars-Sinai Medical Center |
Eduardo Marbán |
Quest – Discovery Stage Research Projects |
New noncoding RNA chemical entity for heart failure with preserved ejection fraction. |
$1,397,412 |
Stanford University |
Dr. Stanley Qi |
Quest – Discovery Stage Research Projects |
A novel hybrid CRISPR tool for gene network perturbation and hiPSC engineering |
$704,661 |
University of California, San Diego |
Ziwei Huang |
Quest – Discovery Stage Research Projects |
Development of a new therapeutic for directing target specific stem cell migration and treatment |
$1,129,512 |
University of California, San Diego |
Dan S Kaufman |
Quest – Discovery Stage Research Projects |
Human iPSC-derived chimeric antigen receptor expressing macrophages for improved cancer treatment. |
$1,256,332 |
Stanford University |
Dr. Marius Wernig MD, PhD |
Quest – Discovery Stage Research Projects |
A universally applicable skin sheet for Dystrophic Epidermolysis Bullosa via next-generation gene editing, iPS cell technology and tissue engineering |
$1,229,040 |
University of California, Davis |
Dr. David J Segal PhD |
Quest – Discovery Stage Research Projects |
AAV9-Cas13 gene therapy for Angelman syndrome |
$1,364,903 |
Stanford University |
Dr. Phillip C Yang |
Quest – Discovery Stage Research Projects |
Hypoxia-specific Production of Exosomes from iPSC-derivatives for Myocardial Repair |
$1,418,023 |
Stanford University |
Kathleen M Sakamoto |
Quest – Discovery Stage Research Projects |
Small Molecules to inhibit Nemo-like Kinase for Treatment of Diamond Blackfan Anemia |
$846,638 |
University of California, Irvine |
Munjal M Acharya |
Quest – Discovery Stage Research Projects |
Stem cell-derived extracellular vesicles to reverse radiation-induced brain injury |
$1,064,108 |
University of California, San Francisco |
Dr Marisa Medina |
Quest – Discovery Stage Research Projects |
iPSCs as a screening tool to predict risk of nonalcoholic fatty liver disease |
$813,000 |
University of California, San Diego |
Tannishtha Reya |
Quest – Discovery Stage Research Projects |
Targeting Critical Regulators of Cancer Stem Cells |
$1,148,264 |
University of California, Davis |
Dr. Deborah K Lieu |
Quest – Discovery Stage Research Projects |
Building a hiPSC-based biopacemaker |
$1,260,827 |
City of Hope, Beckman Research Institute |
Dr. Yanhong Shi Ph.D. |
Quest – Discovery Stage Research Projects |
Combating COVID-19 using human PSC-derived NK cells |
$249,998 |
University of California, San Diego |
Tariq M Rana |
Quest – Discovery Stage Research Projects |
Development of COVID-19 Antiviral Therapy Using Human iPSC-Derived Lung Organoids |
$250,000 |
University of California, Los Angeles |
Dr. Thomas Carmichael M.D., Ph.D. |
Quest – Discovery Stage Research Projects |
Human-induced pluripotent stem cell-derived glial enriched progenitors to treat white matter stroke and vascular dementia. |
$250,000 |
University of California, Irvine |
Robert F. Hunt |
Quest – Discovery Stage Research Projects |
Optimization of a human interneuron cell therapy for traumatic brain injury |
$240,000 |
University of Southern California |
Dr. Justin K Ichida |
Quest – Discovery Stage Research Projects |
Development of a SYF2 antisense oligonucleotide (ASO) treatment for ALS |
$222,300 |
University of California, Irvine |
Dr. Mathew Blurton-Jones |
Quest – Discovery Stage Research Projects |
Transplantation of Pluripotent Stem Cell Derived Microglia for the Treatment of Adult-onset Leukoencephalopathy (HDLS/ALSP) |
$214,668 |
Vitabolus, Inc. |
Aline M Betancourt |
Quest – Discovery Stage Research Projects |
The First Orally Delivered Cell Therapy for the Treatment of Inflammatory Bowel Disease |
$249,000 |
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center |
Dr Eiji Yoshihara PhD |
Quest – Discovery Stage Research Projects |
Dual angiogenic and immunomodulating nanotechnology for subcutaneous stem cell derived islet transplantation for the treatment of diabetes |
$250,000 |
University of California, Los Angeles |
Dr. Donald B. Kohn |
Quest – Discovery Stage Research Projects |
Hematopoietic Stem Cell Gene Therapy for X-linked Agammaglobulinemia |
$219,230 |
University of California, San Diego |
Dan S Kaufman |
Quest – Discovery Stage Research Projects |
Human iPSC-derived chimeric antigen receptor-expressing macrophages for cancer treatment |
$222,200 |
Stanford University |
Alan G Cheng |
Quest – Discovery Stage Research Projects |
Modulation of the Wnt pathway to restore inner ear function |
$1,389,416 |
University of California, San Diego |
Prof James S Hagood |
Quest – Discovery Stage Research Projects |
Mesenchymal stem cell extracellular vesicles as therapy for pulmonary fibrosis |
$0 |
University of Southern California |
Dr. Neil Segil |
Quest – Discovery Stage Research Projects |
A screen for drugs to protect against chemotherapy-induced hearing loss, using sensory hair cells derived by direct lineage reprogramming from hiPSCs |
$741,574 |
Salk Institute for Biological Studies |
Ronald Mark Evans |
Quest – Discovery Stage Research Projects |
Therapeutic immune tolerant human islet-like organoids (HILOs) for Type 1 Diabetes |
$1,637,209 |
Gladstone Institutes, J. David |
Li Gan |
Quest – Discovery Stage Research Projects |
Develop iPSC-derived microglia to treat progranulin-deficient Frontotemporal Dementia |
$1,547,157 |
University of California, Los Angeles |
Dr. Lili Yang |
Quest – Discovery Stage Research Projects |
Preclinical Development of An HSC-Engineered Off-The-Shelf iNKT Cell Therapy for Cancer |
$1,404,000 |
University of California, San Diego |
Dr. Eric D. Adler MD |
Quest – Discovery Stage Research Projects |
Genetically Modified Hematopoietic Stem Cells for the Treatment of Danon Disease |
$1,393,200 |
Stanford University |
Dr. Katja Weinacht |
Quest – Discovery Stage Research Projects |
Regenerative Thymic Tissues as Curative Cell Therapy for Patients with 22q11 Deletion Syndrome |
$1,251,720 |
City of Hope, Beckman Research Institute |
Dr Saul J Priceman |
Quest – Discovery Stage Research Projects |
Chimeric Antigen Receptor-Engineered Stem/Memory T Cells for the Treatment of Recurrent Ovarian Cancer |
$1,351,174 |
Stanford University |
Dr. Philip Arden Beachy PhD |
Quest – Discovery Stage Research Projects |
Pluripotent stem cell-derived bladder epithelial progenitors for definitive cell replacement therapy of bladder cancer |
$1,265,436 |
Calibr |
Stuart A Lipton |
Quest – Discovery Stage Research Projects |
Drug Development for Autism Spectrum Disorder Using Human Patient iPSCs |
$1,827,576 |
University of California, San Francisco |
Dr. Hideho Okada |
Quest – Discovery Stage Research Projects |
Non-viral reprogramming of the endogenous TCRα locus to direct stem memory T cells against shared neoantigens in malignant gliomas |
$900,000 |
Children’s Hospital of Los Angeles |
Dr. Mark R Frey |
Quest – Discovery Stage Research Projects |
Universal Pluripotent Liver Failure Therapy (UPLiFT) |
$1,297,512 |
University of California, San Diego |
Dr. Jonathan H Lin |
Quest – Discovery Stage Research Projects |
Small Molecule Proteostasis Regulators to Treat Photoreceptor Diseases |
$1,153,937 |
University of California, Irvine |
Dr. Aileen J Anderson |
Quest – Discovery Stage Research Projects |
Generation and in vitro profiling of neural stem cell lines to predict in vivo efficacy for chronic cervical spinal cord injury. |
$1,575,613 |
University of California, San Francisco |
Dr. Shuvo Roy |
Quest – Discovery Stage Research Projects |
Silicon Nanopore Membrane encapsulated enriched-Beta Clusters for Type 1 Diabetes treatment |
$1,113,000 |
University of California, Los Angeles |
Dr. Scott G Kitchen |
Quest – Discovery Stage Research Projects |
Engineering Lifelong Cellular Immunity to HIV |
$1,701,178 |
University of California, San Diego |
Tannishtha Reya |
Quest – Discovery Stage Research Projects |
Targeting Cancer Stem Cells in Hematologic Malignancies |
$1,960,560 |
University of California, Los Angeles |
Dr. Thomas Carmichael M.D., Ph.D. |
Quest – Discovery Stage Research Projects |
iPS Glial Therapy for White Matter Stroke and Vascular Dementia |
$2,086,130 |